UTA Acquisition (UTAWF) 10-Q 13 Jan 22 2021 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Sep. 30, 2021	Jan. 13, 2022
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2021
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q3
Entity Registrant Name	UTA Acquisition Corporation
Entity Central Index Key	0001879221
Current Fiscal Year End Date	--12-31
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	true
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity File Number	001-41114
Entity Incorporation, State or Country Code	E9
Entity Tax Identification Number	98-1616250
Entity Address, Address Line One	135 5th Avenue
Entity Address, Address Line Two	7th Floor
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10010
City Area Code	917
Local Phone Number	781-1679
Document Quarterly Report	true
Document Transition Report	false
Units
Document Information [Line Items]
Security 12b Title	Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant
Trading Symbol	UTAAU
Security Exchange Name	NASDAQ
Class A Ordinary Shares
Document Information [Line Items]
Security 12b Title	Class A ordinary shares, par value $0.0001 per share
Trading Symbol	UTAA
Security Exchange Name	NASDAQ
Entity Common Stock, Shares Outstanding		34,200,000
Redeemable Warrants
Document Information [Line Items]
Security 12b Title	Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
Trading Symbol	UTAAW
Security Exchange Name	NASDAQ
Class B Ordinary Shares
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		5,750,000

Condensed Balance Sheet

Condensed Balance Sheet	Sep. 30, 2021USD ($)
Assets:
Prepaid expenses	$ 25,000
Deferred offering costs associated with the proposed public offering	421,440
Total assets	446,440
Current liabilities
Accrued expenses	16,505
Accrued offering costs	299,915
Promissory note - related party	121,525
Total Current Liabilities	437,945
Commitments and Contingencies
Shareholder’s Equity:
Preference shares, $0.0001 par value; 1,000,000 shares authorized, none issued and outstanding
Additional paid-in capital	24,425
Accumulated deficit	(16,505)
Total Shareholder’s Equity	8,495
Total Liabilities and Shareholder’s Equity	446,440
Class B Ordinary Shares
Shareholder’s Equity:
Ordinary shares	575	[1],[2]
Total Shareholder’s Equity	$ 575	[2]
[1]	In November 2021, the Sponsor surrendered 1,437,500 Class B ordinary shares for no consideration, resulting in an aggregate of 5,750,000 Class B ordinary shares outstanding. All share and per-share amounts have been retroactively restated to reflect the share surrender (see Note 7).
[2]	Includes up to 750,000 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriter (see Note 4).

Condensed Balance Sheet (Parent

Condensed Balance Sheet (Parenthetical) - USD ($)	1 Months Ended
	Nov. 30, 2021	Sep. 30, 2021
Preferred stock, par value		$ 0.0001
Preferred stock, shares authorized		1,000,000
Preferred stock, shares issued		0
Preferred stock, shares outstanding		0
Class A Ordinary Shares
Common stock, par value		$ 0.0001
Common stock, shares authorized		80,000,000
Common stock, shares issued		0
Common stock, shares outstanding		0
Class B Ordinary Shares
Common stock, par value		$ 0.0001
Common stock, shares authorized		20,000,000
Common stock, shares issued		5,750,000
Common stock, shares outstanding		5,750,000
Class B Ordinary Shares | Subsequent Event
Common stock, shares outstanding	5,750,000
Class B Ordinary Shares | Subsequent Event | Sponsor
Ordinary shares surrendered	1,437,500
Ordinary shares surrendered, consideration amount	$ 0
Class B Ordinary Shares | Maximum
Ordinary shares subject to forfeiture if the over-allotment option is not exercised		750,000

Condensed Statement of Operatio

Condensed Statement of Operations (Unaudited)	3 Months Ended
	Sep. 30, 2021USD ($)$ / sharesshares
Income Statement [Abstract]
Formation and operating costs	$ 16,505
Net loss	$ (16,505)
Weighted average shares outstanding, basic and diluted | shares	5,000,000	[1],[2]
Basic and diluted net loss per ordinary share | $ / shares	$ 0
[1]	Excludes up to 750,000 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriter (see Note 4).
[2]	In November 2021, the Sponsor surrendered 1,437,500 Class B ordinary shares for no consideration, resulting in an aggregate of 5,750,000 Class B ordinary shares outstanding. All share and per-share amounts have been retroactively restated to reflect the share surrender (see Note 7).

Condensed Statement of Operat_2

Condensed Statement of Operations (Parenthetical) (Unaudited) - Class B Ordinary Shares - USD ($)	1 Months Ended
	Nov. 30, 2021	Sep. 30, 2021
Common stock, shares outstanding		5,750,000
Subsequent Event
Common stock, shares outstanding	5,750,000
Subsequent Event | Sponsor
Ordinary shares surrendered	1,437,500
Ordinary shares surrendered, consideration amount	$ 0
Maximum
Ordinary shares subject to forfeiture if the over-allotment option is not exercised		750,000

Condensed Statement of Changes

Condensed Statement of Changes in Stockholder's Equity (Unaudited) - 3 months ended Sep. 30, 2021 - USD ($)		Total	Class B Ordinary Shares		Additional Paid-in Capital	Accumulated Deficit
Balance at Jul. 14, 2021		$ 0	$ 0	[1]	$ 0	$ 0
Balance, Shares at Jul. 14, 2021	[1]		0
Issuance of Class B ordinary shares to Sponsor	[1],[2]	25,000	$ 575		24,425
Issuance of Class B ordinary shares to Sponsor, Shares	[1],[2]		5,750,000
Net loss		(16,505)				(16,505)
Balance at Sep. 30, 2021		$ 8,495	$ 575	[1]	$ 24,425	$ (16,505)
Balance – September 30, 2021, Shares at Sep. 30, 2021	[1]		5,750,000
[1]	Includes up to 750,000 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriter (see Note 4).
[2]	In November 2021, the Sponsor surrendered 1,437,500 Class B ordinary shares for no consideration, resulting in an aggregate of 5,750,000 Class B ordinary shares outstanding. All share and per-share amounts have been retroactively restated to reflect the share surrender (see Note 7).

Condensed Statement of Change_2

Condensed Statement of Changes in Stockholder's Equity (Parenthetical) (Unaudited) - Class B Ordinary Shares - USD ($)	1 Months Ended
	Nov. 30, 2021	Sep. 30, 2021
Common stock, shares outstanding		5,750,000
Maximum
Ordinary shares subject to forfeiture if the over-allotment option is not exercised		750,000
Subsequent Event
Common stock, shares outstanding	5,750,000
Subsequent Event | Sponsor
Ordinary shares surrendered	1,437,500
Ordinary shares surrendered, consideration amount	$ 0

Condensed Statements of Cash Fl

Condensed Statements of Cash Flows (Unaudited)	3 Months Ended
	Sep. 30, 2021USD ($)
Cash flows from Operating Activities:
Net loss	$ (16,505)
Adjustments to reconcile net loss to net cash used in operating activities:
Change in accrued expenses	16,505
Net Change in Cash	0
Supplemental disclosure of non-cash investing and financing activities:
Deferred offering costs included in accrued offering costs	299,915
Deferred offering costs funded by Sponsor in exchange for promissory note	121,525
Prepaid offering and formation costs funded by Sponsor in exchange for Founder Shares	$ 25,000

Description of Organization, Bu

Description of Organization, Business Operations and Basis of Presentation	3 Months Ended
	Sep. 30, 2021
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Description of Organization, Business Operations and Basis of Presentation	Note 1—Description of Organization, Business Operations and Basis of Presentation UTA Acquisition Corporation (the “Company”) was incorporated as a Cayman Island exempted company on July 15, 2021. The Company was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses (the “Business Combination”). As of September 30, 2021, the Company had not commenced any operations. All activity for the period from July 15, 2021 (inception) through Sponsor The Company’s sponsor is UTA Acquisition Sponsor, LLC (the “Sponsor”). The Company’s ability to commence operations is contingent upon obtaining adequate financial resources through a proposed public offering (the “Proposed Public Offering”) of 20,000,000 units (each, a “Unit” and collectively, the “Units”) at $10.00 per Unit (or 23,000,000 units if the underwriters’ over-allotment option is exercised in full), which is discussed in Note 3, and the sale of 10,000,000 private placement warrants (or up to 11,200,000 warrants if the underwriters’ over-allotment option is exercised in full) (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”), at a price of $1.00 per Private Placement Warrant in a private placement that will close simultaneously with the Proposed Public Offering, which is discussed in Note 4. Business Combination The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Proposed Public Offering and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the net assets held in the Trust Account (as defined below) (net of amounts disbursed to management for working capital purposes and excluding the amount of any deferred underwriting discount held in trust) at the time of the agreement to enter into the initial Business Combination. The Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act 1940, as amended (the “Investment Company Act”). Upon the closing of the Proposed Public Offering, management has agreed that an amount equal to at least $10.00 per Unit sold in the Proposed Public Offering, including the proceeds from the sale of the Private Placement Warrants to the Sponsor, will be held in a trust account (“Trust Account”), located in the United States and invested only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 of the Investment Company Act, which invest only in direct U.S. government treasury obligations, until the earlier of: (i) the completion of a Business Combination or (ii) the distribution of the funds held in the Trust Account as described below. The offer. Topic “ The Company will not redeem the Public Shares in an amount that would cause its net tangible assets to be less than $5,000,005. The law, The Certificate of Incorporation will provide that a Public Shareholder, together with any affiliate of such shareholder or any other person with The (i) (ii) If the Company is unable to complete a Business Combination within 21 months from the closing of the Proposed Public Offering (the “Combination The holders of the Company’s Founder Shares prior to the Proposed Public Offering (the “initial shareholders”) have agreed to waive their rights to liquidating distributions from the Trust Account with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the initial shareholders or the Company’s officers and directors acquire Public Shares in or after the Proposed Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to the deferred underwriting commission (see Note 5) held in the Trust Account in the event the Company does not complete a Business Combination within in the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.00. In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party (except for the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target with which the Company has entered into a letter of intent, confidentiality or other similar agreement or business combination agreement (a “Target”), reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per Public Share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or Target that executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of the Proposed Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except for the Company’s independent registered public accounting firm), prospective targets or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. Going Concern Consideration As of September 30, 2021, the Company had no cash balance and working capital of $8,495. The Company has incurred and expects to continue to incur significant costs in pursuit of its financing and acquisition plans. These conditions raise substantial doubt about the Company’s ability to continue as a going concern one year from the issuance date of the financial statements. Management plans to address this uncertainty through a Proposed Public Offering as discussed in Note 3 and issuance of an unsecured promissory note with principal up to $300,000 to the Sponsor as discussed in Note 4. There is no assurance that the Company’s plans to consummate a Business Combination will be successful within the Combination Period. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended
	Sep. 30, 2021
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 2—Summary of Significant Accounting Policies Basis of Presentation The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of financial position, results of operations, and cash flows for the interim periods presented have been reflected herein. The results of operations for the period from July 15, 2021 (inception) through September 30, 2021 are not necessarily indicative of the results to be expected through December 31, 2021, or for any future periods. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of the unaudited condensed financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities during the reporting period and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. Cash and Cash Equivalents We consider all highly liquid investments with an original maturity of three months or less to be “cash equivalents.” Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage limit of $250,000. As of September 30, 2021, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. Deferred Offering Costs Deferred offering costs consist of legal, accounting, and other costs incurred through the balance sheet date that are directly related to the Proposed Public Offering and will be charged to stockholder’s equity (additional paid-in capital) upon the completion of the Proposed Public Offering. Should the Proposed Public Offering prove to be unsuccessful, these deferred costs, as well as additional expenses to be incurred, will be charged to operations. Net Loss Per Ordinary Share The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” Net loss per share is computed by dividing net loss by the weighted average number of Class B ordinary shares outstanding during the period, excluding ordinary shares subject to forfeiture. Weighted average shares were reduced for the effect of an aggregate of up to 750,000 Class B ordinary shares that are subject to forfeiture to the extent that the over-allotment option is not exercised by the underwriters (see Note 4). As of September 30, 2021, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted loss per ordinary share is the same as basic loss per ordinary share for the period presented. Income Taxes The Company follows the asset and liability method of accounting for income taxes under FASB ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. Deferred tax assets were deemed immaterial as of September 30, 2021. FASB ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of September 30, 2021. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties as of September 30, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals, or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. The provision for income taxes was deemed to be de minimis for the period from July 15, 2021 (inception) through September 30, 2021. Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature. Fair Value Measurement ASC 820 establishes a fair value hierarchy that prioritizes and ranks the level of observability of inputs used to measure investments at fair value. The observability of inputs is impacted by a number of factors, including the type of investment, characteristics specific to the investment, market conditions and other factors. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level I measurements) and the lowest priority to unobservable inputs (Level III measurements). Investments with readily available quoted prices or for which fair value can be measured from quoted prices in active markets will typically have a higher degree of input observability and a lesser degree of judgment applied in determining fair value. The three levels of the fair value hierarchy under ASC 820 are as follows: Level I—Quoted prices (unadjusted) in active markets for identical investments at the measurement date are used. Level II—Pricing inputs are other than quoted prices included within Level I that are observable for the investment, either directly or indirectly. Level II pricing inputs include quoted prices for similar investments in active markets, quoted prices for identical or similar investments in markets that are not active, inputs other than quoted prices that are observable for the investment, and inputs that are derived principally from or corroborated by observable market data by correlation or other means. Level III—Pricing inputs are unobservable and include situations where there is little, if any, market activity for the investment. The inputs used in determination of fair value require significant judgment and estimation. In some cases, the inputs used to measure fair value might fall within different levels of the fair value hierarchy. In such cases, the level in the fair value hierarchy within which the investment is categorized in its entirety is determined based on the lowest level input that is significant to the investment. Assessing the significance of a particular input to the valuation of an investment in its entirety requires judgment and considers factors specific to the investment. The categorization of an investment within the hierarchy is based upon the pricing transparency of the investment and does not necessarily correspond to the perceived risk of that investment. Recent Accounting Pronouncements The Company’s management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements.

Proposed Public Offering

Proposed Public Offering	3 Months Ended
	Sep. 30, 2021
Proposed Public Offering [Abstract]
Proposed Public Offering	Note 3—Proposed Public Offering Pursuant to the Proposed Public Offering, the Company intends to offer for sale 20,000,000 units at a price of $10.00 per Unit. Each Unit consists of one Class A ordinary share (such ordinary shares included in the Units being offered, the “Public Shares”), and one-half of one redeemable warrant (each, a “Public Warrant”). Each whole Public Warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment (see Note 6). The Company will grant the underwriters a 45-day option from the date of the final prospectus relating to the Proposed Public Offering to purchase up to 3,000,000 additional Class A ordinary shares to cover over-allotments, if any, at the Proposed Public Offering price, less underwriting discounts, and commissions.

Related Party Transactions

Related Party Transactions	3 Months Ended
	Sep. 30, 2021
Related Party Transactions [Abstract]
Related Party Transactions	Note 4—Related Party Transactions Founder Shares On July 22, 2021, the Sponsor paid an aggregate price of $25,000 to cover certain expenses on behalf of the Company in exchange for the issuance of 5,750,000 shares of Class B ordinary shares (the “Founder Shares”). The Founder Shares include an aggregate of up to 750,000 shares subject to forfeiture to the extent that the underwriters’ over-allotment option is not exercised in full or in part, so that the Founder Shares will equal, on an as-converted basis, approximately 20% of the Company’s issued and outstanding ordinary shares after the Proposed Public Offering. If the Company increases or decreases the size of the offering, the Company will effect a stock dividend or share contribution back to capital, as applicable, immediately prior to the consummation of the Proposed Public Offering in such amount as to maintain the Founder Share ownership of the Company’s stockholders prior to the Proposed Public Offering at 20% of the Company’s issued and outstanding ordinary shares upon the consummation of the Proposed Public Offering. The initial shareholders, including the Sponsor, have agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier to occur of: (i) one year after the completion of the initial Business Combination and (ii) subsequent to our initial business combination (x) if the last reported sale price of our Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share dividends, rights issuances, consolidations, reorganizations, recapitalizations and other similar transactions) for any 20 trading days within any 30-trading day period commencing at least 150 days after our initial business combination or (y) the date on which we complete a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of our public shareholders having the right to exchange their ordinary shares for cash, securities or other property. Private Placement Warrants The Sponsor has agreed to purchase an aggregate of 10,000,000 Private Placement Warrants (or up to 11,200,000 Private Placement Warrants if the underwriters’ over-allotment option is exercised in full), at a price of $1.00 per Private Placement Warrant ($10,000,000 in the aggregate, or $11,200,000 if the underwriters’ over-allotment option is exercised in full) in a private placement that will occur simultaneously with the closing of the Proposed Public Offering. Each whole Private Placement Warrant is exercisable for one whole Class A ordinary share at a price of $11.50 per share. A portion of the proceeds from the sale of the Private Placement Warrants to the Sponsor will be added to the proceeds from the Proposed Public Offering to be held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the Private Placement Warrants will expire worthless. The Private Placement Warrants will be non-redeemable for cash and exercisable for cash or on a cashless basis so long as they are held by the Sponsor or its permitted transferees. The Sponsor and the Company’s officers and directors have agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants until 30 days after the completion of the initial Business Combination. Promissory Note—Related Party On July 22, 2021, the Sponsor agreed to loan the Company an aggregate of up to $300,000 to cover expenses related to the Proposed Public Offering pursuant to a promissory note (the “Note”). This loan is non-interest bearing, unsecured and due at the earlier of December 31, 2021, or the completion of the Proposed Public Offering. The loan will be repaid upon the closing of our initial public offering out of the $750,000 of offering proceeds that has been allocated to the payment of offering expenses. As of September 30, 2021, the Company had borrowed $121,525 under the Note. Related Party Loans In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company will repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination or, at the lender’s discretion, up to $2,500,000 of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $1.00 per warrant. The warrants would be identical to the Private Placement Warrants. As of September 30, 2021, the Company had no borrowings under the Working Capital Loans. Administrative Services Agreement The Company will enter into an agreement that will provide that, subsequent to the closing of the Proposed Public Offering and continuing until the earlier of the Company’s consummation of a Business Combination or the Company’s liquidation, the Company will pay an affiliate of the Sponsor a total of $10,000 per month for office space, secretarial and administrative services. The Sponsor, executive officers and directors, or any of their respective affiliates, will be reimbursed for any out-of-pocket expenses incurred in connection with activities on the Company’s behalf such as identifying potential target businesses and performing due diligence on suitable Business Combinations. The Company’s audit committee will review on a quarterly basis all payments that were made to the Sponsor, officers, directors or their affiliates.

Commitment and Contingences

Commitment and Contingences	3 Months Ended
	Sep. 30, 2021
Commitments And Contingencies Disclosure [Abstract]
Commitments and Contingences	Note 5—Commitments and Contingences Registration Rights The holders of Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans, if any, (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans and upon conversion of the Founder Shares) will be entitled to registration rights pursuant to a registration rights agreement to be signed prior to the consummation of the Proposed Public Offering. These holders will be entitled to certain demand and “piggyback” registration rights. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Risks and Uncertainties Management continues to evaluate the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations, closing of the Proposed Public Offering and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. Underwriting Agreement The underwriters will be entitled to an underwriting discount of $0.20 per unit, or $4,000,000 in the aggregate (or $4,600,000 in the aggregate if the underwriters’ over-allotment option is exercised in full), payable upon the closing of the Proposed Public Offering. Additionally, the underwriters will be entitled to a deferred underwriting discount of $0.35 per unit, or $7,000,000 in the aggregate (or approximately $8,050,000 in the aggregate if the underwriters’ over-allotment option is exercised in full). The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.

Shareholder_s Equity

Shareholder’s Equity	3 Months Ended
	Sep. 30, 2021
Equity [Abstract]
Stockholders' Equity	Note 6—Shareholder’s Equity Preference Shares — The Company is authorized to issue 1,000,000 preference shares, par value $0.0001 per share, with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of September 30, 2021, there were no preference shares issued and outstanding. Class A Ordinary Shares —The Company is authorized to issue 80,000,000 Class A ordinary shares with a par value of $0.0001 per share. As of September 30, 2021, there were no Class A ordinary shares issued or outstanding. Class B Ordinary Shares —The Company is authorized to issue 20,000,000 Class B ordinary shares with a par value of $0.0001 per share. On July 22, 2021, the Sponsor paid an aggregate price of $25,000 to cover certain expenses on behalf of the Company in exchange for the issuance of 5,750,000 Class B ordinary shares outstanding, of which an aggregate of up to 750,000 Class B ordinary shares are subject to forfeiture to the extent that the underwriters’ over-allotment option is not exercised in full or in part so that the number of Founder Shares will equal 20% of the Company’s issued and outstanding ordinary shares after the Proposed Public Offering. Stockholders of record are entitled to one vote for each share held on all matters to be voted on by stockholders. Holders of Class A ordinary shares and holders of Class B ordinary shares will vote together as a single class on all matters submitted to a vote of the Company’s stockholders except as required by law. The Class B ordinary shares will automatically convert into Class A ordinary shares at the time of the initial Business Combination, or earlier at the option of the holder, on a one-for-one basis, subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations and the like, and subject to further adjustment as provided herein. In the case that additional shares of Class A ordinary shares or equity-linked securities are issued or deemed issued in connection with the initial Business Combination, the number of shares of Class A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate, on an as-converted basis, 20% of the total number of shares of Class A ordinary shares outstanding after such conversion (after giving effect to any redemptions of shares of Class A ordinary shares by Public Stockholders), including the total number of shares of Class A ordinary shares issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial Business Combination, excluding any shares of Class A ordinary shares or equity-linked securities or rights exercisable for or convertible into shares of Class A ordinary shares issued, or to be issued, to any seller in the initial Business Combination and any Private Placement Warrants issued to the Sponsor, officers or directors upon conversion of Working Capital Loans, provided that such conversion of Founder Shares will never occur on a less than one-for-one basis. Warrants— No The Company will account for the 20,000,000 warrants to be issued in connection with the Proposed Public Offering (representing 10,000,000 Public Warrants and 10,000,000 Private Placement Warrants assuming the underwriters’ over-allotment option is not exercised) in accordance with the guidance contained in ASC 815-40. Such guidance provides that because the warrants meet the criteria for equity treatment thereunder, each warrant must be recorded within equity. Public Warrants may only be exercised for a whole number of shares. No fractional Public Warrants will be issued upon separation of the Units and only whole Public Warrants will trade. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination or (b) 12 months from the closing of the Proposed Public Offering. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. Once the warrants become exercisable, the Company may redeem the Public Warrants: • in whole and not in part; • at a price of $0.01 per warrant; • at any time after the warrants become exercisable; • upon a not less than 30 days’ prior written notice of redemption; • if, and only if, the last sales price of the Class A ordinary shares for any 20 days within a 30-trading day period ending on the third trading day prior to the date on which we send the notice of redemption to the warrant holders equals or exceeds $18.00 per share. • if, and only if, there is a current registration statement in effect with respect to the ordinary shares underlying such warrants at the time of redemption and for the entire 30-day trading period referred to above and continuing each day thereafter until the date of redemption, or the Company has elected to require the exercise of the Public Warrants on a cashless basis. If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of ordinary shares issuable on exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, extraordinary dividend or recapitalization, reorganization, merger, or consolidation. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless. If the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of its initial Business Combination at an issue price or effective issue price of less than $9.20 per Class A ordinary shares (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Class B Ordinary Shares, par value $0.0001 per share, of the Company held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Class A ordinary shares during the 10 trading day period starting on the trading day after the day on which the Company consummates the initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the Warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price. The Private Placement Warrants will be identical to the Public Warrants underlying the Units being sold in the Proposed Public Offering, except that the Private Placement Warrants and ordinary shares issuable upon the exercise may be subject to certain transfer restrictions contained in the letter agreement by and among the Company, the Sponsor and any other parties thereto, as amended from time to time, including that any permitted transferees must enter into a written agreement with the Company agreeing to be bound by the transfer restrictions contained in such letter agreement

Subsequent Events

Subsequent Events	3 Months Ended
	Sep. 30, 2021
Subsequent Events [Abstract]
Subsequent Events	Note 7—Subsequent Events In November 2021, the Sponsor transferred 25,000 Founder Shares each to Nancy Tellem and Alexis Ohanian, the Company’s independent director nominees. In November 2021, the Sponsor surrendered an aggregate of 1,437,500 Founder Shares for no consideration, resulting in an aggregate of 5,750,000 Class B ordinary shares outstanding. All share and per share amounts have been retroactively restated to reflect the share surrender. On December 6, 2021, the Company consummated its initial public offering (the “IPO”) of 23,000,000 units (the “Units”), including the issuance of 3,000,000 Units as a result of the underwriter’s exercise of its over-allotment option. Each Unit consists of one Class A ordinary share of the Company, par value $0.0001 per share (an “Ordinary Share”), and one-half of one redeemable warrant of the Company. Each whole warrant entitles the holder thereof to purchase one Ordinary Share for $11.50 per share, subject to adjustment. The Units were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $230,000,000. Substantially concurrently with the closing of the IPO, the Company completed the private sale of 11,200,000 Private Placement Warrants at a purchase price of $1.00 per Private Placement Warrant, to the Sponsor, generating gross proceeds to the Company of $11,200,000. The Private Placement Warrants are identical to the warrants sold as part of the Units in the IPO except that, so long as they are held by the Sponsor or its permitted transferees: (1) they will not be redeemable by the Company (except in certain redemption scenarios when the price per Ordinary Share equals or exceeds $10.00 (as adjusted)); (2) they (including the Ordinary Shares issuable upon exercise of these warrants) may not, subject to certain limited exceptions, be transferred, assigned or sold by the Sponsor until 30 days after the completion of the Company’s initial business combination; (3) they may be exercised by the holders on a cashless basis; and (4) they (including the Ordinary Shares issuable upon exercise of these warrants) are entitled to registration rights. A total of $234,600,000, comprised of proceeds from the IPO and the sale of the Private Placement Warrants, was placed in the Trust Account, a U.S.-based trust account at JP Morgan Chase Bank, N.A., maintained by Continental Stock Transfer & Trust Company, acting as trustee. Except with respect to interest earned on the funds held in the Trust Account that may be released to the Company to pay its taxes, if any, the funds held in the Trust Account will not be released from the Trust Account until the earliest to occur of: (1) the completion of the Company’s initial business combination; (2) the redemption of any public shares properly submitted in connection with a shareholder vote to amend the Company’s amended and restated memorandum and articles of association (A) to modify the substance or timing of the Company’s obligation to allow redemption in connection with its initial business combination or to redeem 100% of its public shares if the Company does not complete its initial business combination within 21 months from the closing of the IPO or (B) with respect to any other provision relating to shareholders’ rights or pre-initial business combination activity; and (3) the redemption of the Company’s public shares if the Company has not completed its initial business combination within 21 months from the closing of the IPO, subject to applicable law. Substantially concurrently with the closing of the IPO, the Company and its Sponsor agreed to transfer $300,000 of debt outstanding on the Company’s Promissory Note to the Working Capital Loans. The Company has evaluated subsequent events and transactions occurring up to January 13, 2022, the date that the financial statements were issued. Based upon this review, the Company did not identify any subsequent events, other than above, that would have required adjustment or disclosure in the financial statements.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Sep. 30, 2021
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of financial position, results of operations, and cash flows for the interim periods presented have been reflected herein. The results of operations for the period from July 15, 2021 (inception) through September 30, 2021 are not necessarily indicative of the results to be expected through December 31, 2021, or for any future periods.
Emerging Growth Company	Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates	Use of Estimates The preparation of the unaudited condensed financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities during the reporting period and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents We consider all highly liquid investments with an original maturity of three months or less to be “cash equivalents.”
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage limit of $250,000. As of September 30, 2021, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.
Deferred Offering Costs	Deferred Offering Costs Deferred offering costs consist of legal, accounting, and other costs incurred through the balance sheet date that are directly related to the Proposed Public Offering and will be charged to stockholder’s equity (additional paid-in capital) upon the completion of the Proposed Public Offering. Should the Proposed Public Offering prove to be unsuccessful, these deferred costs, as well as additional expenses to be incurred, will be charged to operations.
Net Loss Per Ordinary Share	Net Loss Per Ordinary Share The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” Net loss per share is computed by dividing net loss by the weighted average number of Class B ordinary shares outstanding during the period, excluding ordinary shares subject to forfeiture. Weighted average shares were reduced for the effect of an aggregate of up to 750,000 Class B ordinary shares that are subject to forfeiture to the extent that the over-allotment option is not exercised by the underwriters (see Note 4). As of September 30, 2021, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted loss per ordinary share is the same as basic loss per ordinary share for the period presented.
Income Taxes	Income Taxes The Company follows the asset and liability method of accounting for income taxes under FASB ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. Deferred tax assets were deemed immaterial as of September 30, 2021. FASB ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of September 30, 2021. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties as of September 30, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals, or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. The provision for income taxes was deemed to be de minimis for the period from July 15, 2021 (inception) through September 30, 2021.
Financial Instruments	Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature.
Fair Value Measurement	Fair Value Measurement ASC 820 establishes a fair value hierarchy that prioritizes and ranks the level of observability of inputs used to measure investments at fair value. The observability of inputs is impacted by a number of factors, including the type of investment, characteristics specific to the investment, market conditions and other factors. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level I measurements) and the lowest priority to unobservable inputs (Level III measurements). Investments with readily available quoted prices or for which fair value can be measured from quoted prices in active markets will typically have a higher degree of input observability and a lesser degree of judgment applied in determining fair value. The three levels of the fair value hierarchy under ASC 820 are as follows: Level I—Quoted prices (unadjusted) in active markets for identical investments at the measurement date are used. Level II—Pricing inputs are other than quoted prices included within Level I that are observable for the investment, either directly or indirectly. Level II pricing inputs include quoted prices for similar investments in active markets, quoted prices for identical or similar investments in markets that are not active, inputs other than quoted prices that are observable for the investment, and inputs that are derived principally from or corroborated by observable market data by correlation or other means. Level III—Pricing inputs are unobservable and include situations where there is little, if any, market activity for the investment. The inputs used in determination of fair value require significant judgment and estimation. In some cases, the inputs used to measure fair value might fall within different levels of the fair value hierarchy. In such cases, the level in the fair value hierarchy within which the investment is categorized in its entirety is determined based on the lowest level input that is significant to the investment. Assessing the significance of a particular input to the valuation of an investment in its entirety requires judgment and considers factors specific to the investment. The categorization of an investment within the hierarchy is based upon the pricing transparency of the investment and does not necessarily correspond to the perceived risk of that investment.
Recent Accounting Pronouncements	Recent Accounting Pronouncements The Company’s management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements.

Description of Organization, _2

Description of Organization, Business Operations and Basis of Presentation - Additional Information (Details) - USD ($)	3 Months Ended
	Sep. 30, 2021	Jul. 22, 2021
Class Of Stock [Line Items]
Entity incorporation, date of incorporation	Jul. 15, 2021
Units issued price per share	$ 10
Minimum percentage of initial business combination fair market value of net assets held in trust account	80.00%
Minimum percentage of ownership required to complete business combination	50.00%
Anticipated price per public share	$ 10
Maximum net tangible assets redeem amount	$ 5,000,005
Minimum redeeming percentage of public shares	15.00%
Business combination incomplete redeem percentage of public shares	100.00%
Business combination complete period	21 months
Business combination incomplete, maximum period of redeem public shares	10 days
Business combination incomplete, maximum interest to pay dissolution expenses	$ 100,000
Business combination incomplete, redemption rights or liquidating distributions respect to warrants amount	$ 0
Residual assets value per share remaining available for distribution	$ 10
Business combination agreement, reduce amount of funds in trust account, description	Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per Public Share due to reductions in the value of the trust assets,
Cash	$ 0
Working capital amount	$ 8,495
Class A Ordinary Shares
Class Of Stock [Line Items]
Ordinary shares, par value	$ 0.0001
Maximum
Class Of Stock [Line Items]
Units issued price per share	$ 10
Investments held in trust account maturity period	185 days
Maximum | Unsecured Promissory Note
Class Of Stock [Line Items]
Debt Instrument principal amount	$ 300,000
Minimum [Member]
Class Of Stock [Line Items]
Units issued price per share	$ 10
Proposed Public Offering
Class Of Stock [Line Items]
Units issued during period	20,000,000
Proposed Public Offering | Class A Ordinary Shares
Class Of Stock [Line Items]
Units issued price per share	$ 11.50
Ordinary shares, par value	$ 0.0001
Sponsor | Class A Ordinary Shares
Class Of Stock [Line Items]
Units issued price per share		$ 11.50
Sponsor | Proposed Public Offering
Class Of Stock [Line Items]
Units issued during period	20,000,000
Units issued price per share	$ 10
Sponsor | Over-Allotment Option
Class Of Stock [Line Items]
Units issued during period	23,000,000
Sponsor | Private Placement Warrants
Class Of Stock [Line Items]
Sale of warrants	10,000,000
Sale of warrants price per warrant	$ 1
Sponsor | Private Placement Warrants | Over-Allotment Option | Maximum
Class Of Stock [Line Items]
Sale of warrants	11,200,000

Summary of Significant Accoun_3

Summary of Significant Accounting Policies - Additional Information (Details)	3 Months Ended
	Sep. 30, 2021USD ($)shares
Summary Of Significant Accounting Policies [Line Items]
Federal Depository Insurance Coverage limit	$ 250,000
Unrecognized tax benefits	0
Accrued interest and penalties related to unrecognized tax benefits	$ 0
Over-Allotment Option | Maximum | Class B Ordinary Shares
Summary Of Significant Accounting Policies [Line Items]
Shares subject to forfeiture | shares	750,000

Proposed Public Offering - Addi

Proposed Public Offering - Additional Information (Details)	3 Months Ended
	Sep. 30, 2021$ / sharesshares
Subsidiary Sale Of Stock [Line Items]
Units issued price per share | $ / shares	$ 10
Proposed Public Offering
Subsidiary Sale Of Stock [Line Items]
Units issued during period | shares	20,000,000
Price per unit | $ / shares	$ 10
Proposed public offering description	Each Unit consists of one Class A ordinary share (such ordinary shares included in the Units being offered, the “Public Shares”), and one-half of one redeemable warrant (each, a “Public Warrant”)
Proposed Public Offering | Class A Ordinary Shares
Subsidiary Sale Of Stock [Line Items]
Number of securities called by each warrant | shares	1
Units issued price per share | $ / shares	$ 11.50
Over-Allotment Option
Subsidiary Sale Of Stock [Line Items]
Period granted for underwriters to exercise option	45 days
Over-Allotment Option | Class A Ordinary Shares
Subsidiary Sale Of Stock [Line Items]
Additional shares purchased | shares	3,000,000

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Details) - USD ($)		Jul. 22, 2021	Sep. 30, 2021
Related Party Transaction [Line Items]
Sponsor paid aggregate price	[1],[2]		$ 25,000
Common stock issued, price per share			$ 10
Administrative Services Agreement
Related Party Transaction [Line Items]
Monthly payment to affiliate of sponsor for office space, secretarial and administrative services		$ 10,000
Maximum
Related Party Transaction [Line Items]
Common stock issued, price per share			10
Minimum [Member]
Related Party Transaction [Line Items]
Common stock issued, price per share			$ 10
Class B Ordinary Shares
Related Party Transaction [Line Items]
Sponsor paid aggregate price	[1],[2]		$ 575
Units issued during period	[1],[2]		5,750,000
Class B Ordinary Shares | Maximum
Related Party Transaction [Line Items]
Ordinary shares subject to forfeiture if the over-allotment option is not exercised			750,000
Sponsor | Note
Related Party Transaction [Line Items]
Line of credit facility, maximum borrowing capacity		300,000
Outstanding balance of related party note		$ 750,000
Borrowings			$ 121,525
Sponsor | Class A Ordinary Shares
Related Party Transaction [Line Items]
Common stock issued, price per share		$ 11.50
Number of securities called by each warrant		1
Founder Shares | Sponsor
Related Party Transaction [Line Items]
Threshold period after completion of initial business combination		1 year
Common stock threshold trading days		20 days
Common stock threshold consecutive trading days		30 days
Minimum holding period for shares after business combination		150 days
Founder Shares | Sponsor | Class B Ordinary Shares
Related Party Transaction [Line Items]
Sponsor paid aggregate price		$ 25,000
Units issued during period		5,750,000
Percentage of issued and outstanding ordinary shares after proposed public offering		20.00%
Percentage of issued and outstanding ordinary shares upon consummation of proposed public offering		20.00%
Founder Shares | Sponsor | Class B Ordinary Shares | Maximum
Related Party Transaction [Line Items]
Ordinary shares subject to forfeiture if the over-allotment option is not exercised		750,000
Founder Shares | Sponsor | Class A Ordinary Shares | Maximum
Related Party Transaction [Line Items]
Common stock issued, price per share		$ 12
Warrant | Working Capital Loans
Related Party Transaction [Line Items]
Sale of warrants price per warrant		$ 1
Borrowings			$ 0
Warrant | Private Placement
Related Party Transaction [Line Items]
Warrants holding period after completion of business combination		30 days
Warrant | Maximum | Working Capital Loans
Related Party Transaction [Line Items]
Debt conversion converted instrument amount		$ 2,500,000
Warrant | Sponsor | Private Placement
Related Party Transaction [Line Items]
Sale of warrants		10,000,000
Sale of warrants price per warrant		$ 1
Proceeds from issuance of warrants		$ 10,000,000
Proceeds from issuance of warrants if over-allotment option exercised full		$ 11,200,000
Warrant | Sponsor | Maximum | Private Placement
Related Party Transaction [Line Items]
Number of warrants agreed to purchase if over-allotment option exercised full		11,200,000
[1]	In November 2021, the Sponsor surrendered 1,437,500 Class B ordinary shares for no consideration, resulting in an aggregate of 5,750,000 Class B ordinary shares outstanding. All share and per-share amounts have been retroactively restated to reflect the share surrender (see Note 7).
[2]	Includes up to 750,000 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriter (see Note 4).

Commitment and Contingences - A

Commitment and Contingences - Additional Information (Details)	Sep. 30, 2021$ / sharesshares
Commitments And Contingences [Line Items]
Underwriting discount price per share | $ / shares	$ 0.20
Underwriting discount aggregate number of shares entitled	4,000,000
Deferred underwriting discount price per share | $ / shares	$ 0.35
Deferred underwriting discount aggregate number of shares entitled	7,000,000
Over-Allotment Option
Commitments And Contingences [Line Items]
Underwriting discount aggregate number of shares entitled	4,600,000
Deferred underwriting discount aggregate number of shares entitled	8,050,000

Stockholder's Equity - Addition

Stockholder's Equity - Additional Information (Detail)	3 Months Ended
	Sep. 30, 2021USD ($)$ / sharesshares
Class Of Stock [Line Items]
Preferred stock, shares authorized	1,000,000
Preferred stock, par value | $ / shares	$ 0.0001
Preferred stock, shares issued	0
Preferred stock, shares outstanding	0
Issuance of Class B ordinary shares to Sponsor | $	$ 25,000	[1],[2]
Common stock, voting rights	one
Common stock, conversion basis	one-for-one basis
Percentage of common stock shares outstanding	20.00%
Class of warrants or rights outstanding	0
Percentage of equity proceeds	60.00%
Price of newly issued stock to cause adjustment of exercise warrant price | $ / shares	$ 9.20
Percentage of warrant exercise price adjusted to price received in new issuance	115.00%
Public Warrants
Class Of Stock [Line Items]
Class of warrants or rights, days from which warrants are exercisable	30 days
Class of warrants or rights, months from which warrants are exercisable	12 months
Class of warrants or rights, outstanding term	5 years
Class of warrant or right redemption price | $ / shares	$ 0.01
Warrant | IPO
Class Of Stock [Line Items]
Class of warrants or rights issued during period	20,000,000
Warrant | IPO | Public Warrants
Class Of Stock [Line Items]
Class of warrants or rights issued during period	10,000,000
Warrant | Private Placement | Private Placement Warrants
Class Of Stock [Line Items]
Class of warrants or rights issued during period	10,000,000
Class A Ordinary Shares
Class Of Stock [Line Items]
Common stock, shares authorized	80,000,000
Common stock, par value | $ / shares	$ 0.0001
Common stock, shares issued	0
Common stock, shares outstanding	0
Class A Ordinary Shares | Maximum
Class Of Stock [Line Items]
Initial business combination effective issue price per share | $ / shares	$ 9.20
Class A Ordinary Shares | Public Warrants
Class Of Stock [Line Items]
Number of trading days for determining the share price	20 days
Number of consecutive trading days for determining the share price	30 days
Common stock redemption stock price per share | $ / shares	$ 18
Class A Ordinary Shares | IPO
Class Of Stock [Line Items]
Common stock, par value | $ / shares	$ 0.0001
Class B Ordinary Shares
Class Of Stock [Line Items]
Common stock, shares authorized	20,000,000
Common stock, par value | $ / shares	$ 0.0001
Common stock, shares issued	5,750,000
Common stock, shares outstanding	5,750,000
Issuance of Class B ordinary shares to Sponsor | $	$ 575	[1],[2]
Common stock shares subject to forfeiture if overallotment option was not exercised	750,000
Class B Ordinary Shares | Sponsor
Class Of Stock [Line Items]
Issuance of Class B ordinary shares to Sponsor | $	$ 25,000
Class B Ordinary Shares | Founder Shares
Class Of Stock [Line Items]
Percentage of issued and outstanding ordinary shares	20.00%
[1]	In November 2021, the Sponsor surrendered 1,437,500 Class B ordinary shares for no consideration, resulting in an aggregate of 5,750,000 Class B ordinary shares outstanding. All share and per-share amounts have been retroactively restated to reflect the share surrender (see Note 7).
[2]	Includes up to 750,000 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriter (see Note 4).

Subsequent Events - Additional

Subsequent Events - Additional Information (Detail) - USD ($)		Jul. 22, 2021	Dec. 06, 2021	Nov. 30, 2021	Sep. 30, 2021
Subsequent Event [Line Items]
Common stock issued, price per share					$ 10
IPO
Subsequent Event [Line Items]
Issuance of Class B ordinary shares to Sponsor, Shares					20,000,000
Class B Ordinary Shares
Subsequent Event [Line Items]
Common stock, shares outstanding					5,750,000
Issuance of Class B ordinary shares to Sponsor, Shares	[1],[2]				5,750,000
Common stock, shares issued					5,750,000
Common stock, par value					$ 0.0001
Class A Ordinary Shares
Subsequent Event [Line Items]
Common stock, shares outstanding					0
Common stock, shares issued					0
Common stock, par value					$ 0.0001
Class A Ordinary Shares | IPO
Subsequent Event [Line Items]
Common stock, par value					0.0001
Common stock issued, price per share					$ 11.50
Sponsor | IPO
Subsequent Event [Line Items]
Issuance of Class B ordinary shares to Sponsor, Shares					20,000,000
Common stock issued, price per share					$ 10
Sponsor | Over-Allotment Option
Subsequent Event [Line Items]
Issuance of Class B ordinary shares to Sponsor, Shares					23,000,000
Sponsor | Class A Ordinary Shares
Subsequent Event [Line Items]
Common stock issued, price per share		$ 11.50
Founder Shares | Sponsor | Class B Ordinary Shares
Subsequent Event [Line Items]
Issuance of Class B ordinary shares to Sponsor, Shares		5,750,000
Warrant | Working Capital Loans
Subsequent Event [Line Items]
Sale of warrants price per warrant		$ 1
Warrant | Sponsor | Private Placement
Subsequent Event [Line Items]
Sale of warrants price per warrant		$ 1
Sale of warrants		10,000,000
Subsequent Event | Working Capital Loans
Subsequent Event [Line Items]
Transfer of debt outstanding			$ 300,000
Subsequent Event | IPO
Subsequent Event [Line Items]
Issuance of Class B ordinary shares to Sponsor, Shares			23,000,000
Sale of warrants price per warrant			$ 11.50
Share price, per share			$ 10
Gross proceeds from issuance of initial public offering			$ 230,000,000
Subsequent Event | Over-Allotment Option
Subsequent Event [Line Items]
Common stock, shares issued			3,000,000
Subsequent Event | Class B Ordinary Shares
Subsequent Event [Line Items]
Common stock, shares outstanding				5,750,000
Subsequent Event | Class A Ordinary Shares | IPO
Subsequent Event [Line Items]
Common stock, par value			$ 0.0001
Subsequent Event | Sponsor | Class B Ordinary Shares
Subsequent Event [Line Items]
Ordinary shares surrendered				1,437,500
Ordinary shares surrendered, consideration amount				$ 0
Subsequent Event | Founder Shares | Class B Ordinary Shares
Subsequent Event [Line Items]
Common stock, shares outstanding				5,750,000
Subsequent Event | Founder Shares | Sponsor
Subsequent Event [Line Items]
Shares transferred				25,000
Subsequent Event | Founder Shares | Sponsor | Class B Ordinary Shares
Subsequent Event [Line Items]
Ordinary shares surrendered				1,437,500
Ordinary shares surrendered, consideration amount				$ 0
Subsequent Event | Warrant | Private Placement
Subsequent Event [Line Items]
Percentage of public shares to be redeemed within eighteen months from closing of initial public offering			100.00%
Subsequent Event | Warrant | Sponsor | Private Placement
Subsequent Event [Line Items]
Sale of warrants price per warrant			$ 1
Gross proceeds from issuance of initial public offering			$ 11,200,000
Sale of warrants			11,200,000
Common stock issued, price per share			$ 10
Subsequent Event | Warrant | Continental Stock Transfer & Trust Company | Private Placement
Subsequent Event [Line Items]
Gross proceeds from issuance of initial public offering			$ 234,600,000
[1]	In November 2021, the Sponsor surrendered 1,437,500 Class B ordinary shares for no consideration, resulting in an aggregate of 5,750,000 Class B ordinary shares outstanding. All share and per-share amounts have been retroactively restated to reflect the share surrender (see Note 7).
[2]	Includes up to 750,000 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriter (see Note 4).